Britannica Sources used in this answer

Why can combinations of HIV drugs slow the development of drug-resistant viruses?

Created from Britannica articles using AI. AI can make mistakes, so verify using Britannica articles.

Diagram illustrating the process of retrovirus infection and reverse transcription, showing a retrovirus entering a host cell, releasing viral RNA, reverse transcriptase converting RNA to DNA, integration into the host genome, transcription of new viral RNA, assembly of new virions, and budding from the cell. — Reverse transcriptase After a retrovirus infects a cell, an enzyme known as reverse transcriptase converts viral RNA into proviral DNA in the cytoplasm. Proviral DNA then enters the nucleus, where it is incorporated into the host cell's DNA.

HIV replicates continuously at a very high rate, creating numerous opportunities for mutation and the emergence of strains resistant to individual drugs. When a single antiretroviral drug is used, it kills nonresistant viruses but leaves behind mutants that can multiply without competition, leading to a drug-resistant population.12

To slow the development of this resistance, clinicians use combination therapies, such as highly active antiretroviral therapy (HAART). These combinations are effective for several reasons:34

Synergistic Inhibition: Drugs that act at different points in the HIV life cycle—such as reverse transcriptase inhibitors and protease inhibitors—suppress viral replication more effectively than any single agent alone.14
Multiple Barriers: By attacking the virus through different mechanisms simultaneously, the treatment makes it significantly more difficult for the virus to develop the multiple mutations required to survive all the drugs in the regimen.14

Consistent adherence to these prescribed combinations is essential, as missed doses can lower drug concentrations and increase the risk of the virus developing resistance.32